15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Globe Life Inc, 7 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $166.00 to $215.00, so the covering firms are broadly aligned. The average target of $192.89 sits 8% above the current $179.09. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.80 next quarter toward $16.57 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy770%
Hold330%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Globe Life Inc.
As of Jul, 7 of 9 firms rate GL a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GL EPS & revenue forecast
EPS · NEXT QUARTER
$3.80
Range $3.74 – $3.97 · 9 analysts · +12% YoY
Next period, 9 analysts expect Globe Life Inc to earn $3.80 a share (range $3.74 – $3.97), versus $3.39 a year earlier. Full-year consensus is $15.68, growing to $16.57 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.6B – $1.6B · 9 analysts · +8% YoY
Revenue is expected to reach $1.6B (range $1.6B – $1.6B), +7.6% year-over-year. Full-year consensus is $6.4B, rising to $6.8B next year.
Top analysts covering Globe Life Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GL.
#1
Elyse Greenspan
Wells Fargo · Rank #44
Buy
$172.00-4.0% to target
Overall win rate
56%
+ Follow
#2
Mark Hughes
Truist Securities · Rank #214
Buy
$185.00+3.3% to target
Overall win rate
32%
+ Follow
#3
Paul Newsome
Piper Sandler · Rank #252
Buy
$200.00+11.7% to target
Overall win rate
45%
+ Follow
#4
BH
Bob Huang
Morgan Stanley
Buy
$208.00+16.1% to target
Coverage
—
+ Follow
#5
Andrew Kligerman
TD Cowen
Buy
$225.00+25.6% to target
Coverage
—
+ Follow
GL stock forecast FAQ
What is GL's average 12-month price target?+
The 9 analysts with a live target average $192.89 for Globe Life Inc over the next 12 months, ranging from a $215.00 high to a $166.00 low.
Is GL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for GL?+
The Street-high target is $215.00 (TD Cowen), and the Street-low is $166.00 (Jefferies). The average of all 9 active targets is $192.89.
How many Wall Street analysts cover GL?+
10 analysts have an active rating on Globe Life Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering GL?+
Among analysts who currently cover GL, Elyse Greenspan of Wells Fargo has the strongest overall Quantellect track record (Rank #44). Their current call is Buy with a $172.00 target.
What is Globe Life Inc's projected EPS for next quarter?+
The consensus estimate is $3.80 per share (range $3.74 – $3.97) across 9 analysts. Full-year EPS is projected at $15.68, rising to $16.57 the following year.
How much revenue is Globe Life Inc expected to report next quarter?+
Consensus revenue is $1.6B (range $1.6B – $1.6B). Full-year revenue is projected at $6.4B, growing to $6.8B next year.
Have analysts been upgrading or downgrading GL lately?+
As of Jul, 7 of 9 firms rate GL a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
